General Information of Drug (ID: DMIECOF)

Drug Name
PMID19831390C14 Drug Info
Synonyms 1116571-01-7; GTPL8151; ZINC45254830; BDBM50299583; AKOS027339246; KB-66522; AS-40572
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
44477445
TTD Drug ID
DMIECOF

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID22902653C30 DMXDTPL Discovery agent N.A. Investigative [2]
PMID22902653C31 DMWVTAE Discovery agent N.A. Investigative [2]
PMID22902653C35 DMLVKPG Discovery agent N.A. Investigative [2]
PMID19831390C22m DM8T6VG Discovery agent N.A. Investigative [1]
Drug Name Drug ID Indication ICD 11 Highest Status REF
RKI-1447 DMGTAWC Discovery agent N.A. Investigative [3]
PMID22902653C30 DMXDTPL Discovery agent N.A. Investigative [2]
PMID22902653C31 DMWVTAE Discovery agent N.A. Investigative [2]
PMID22902653C35 DMLVKPG Discovery agent N.A. Investigative [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
LIM domain kinase-1 (LIMK-1) TTWL9TY LIMK1_HUMAN Inhibitor [1]
LIM domain kinase-2 (LIMK-2) TTASMD8 LIMK2_HUMAN Inhibitor [1]

References

1 Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma. J Med Chem. 2009 Nov 12;52(21):6515-8.
2 Modulation of cofilin phosphorylation by inhibition of the Lim family kinases. Bioorg Med Chem Lett. 2012 Sep 15;22(18):5995-8.
3 Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2). Medchemcomm. 2012 Jun 1;3(6):699-709.